# Clinical studies with a Saudi site registered on ClinicalTrials.gov, to 2025

Source: https://onco.cc/key-papers/paper-aldurdunji-saudi-clinicaltrials-gov-medicine-2026/  
OnCo record `paper-aldurdunji-saudi-clinicaltrials-gov-medicine-2026` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Of 1,502 studies with a Saudi site registered on ClinicalTrials.gov to August 2025, three quarters were interventional, most were sponsored by non-industry bodies, activity clustered in Riyadh, and only 12.1% had posted results.

## Summary

Published as "Trends in clinical research in Saudi Arabia: A registry-based descriptive analysis of ClinicalTrials.gov to 2025". A descriptive analysis of every study registered on ClinicalTrials.gov with at least one Saudi site through August 2025, by sponsor, design, phase, enrolment, city and therapeutic area.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: Medicine
- Year: 2026
- DOI: 10.1097/md.0000000000048740
- Authors: Aldurdunji MM.
- Findings: 1,502 studies; 75.5% interventional, with more late-phase (phase 3) than early-phase research.; Non-industry sponsors registered 73.0%; half of trials planned 100 or fewer participants.; Activity concentrated in Riyadh, with smaller hubs in Jeddah and Dammam; 12.1% of studies had posted results; oncology was among the most represented areas.
- What it means: Saudi Arabia increasingly joins multinational late-phase trials, but early-phase capacity, research outside the big cities and results reporting lag.
- Caveats: ClinicalTrials.gov only; the Saudi Clinical Trials Registry is not included.; The abstract does not give an oncology count.

## Sources

- Medicine 2026: https://doi.org/10.1097/md.0000000000048740
- PubMed: https://pubmed.ncbi.nlm.nih.gov/42152297/

## Connected records

- institutions: [National Cancer Center, Saudi Health Council](https://onco.cc/institutions/saudi-national-cancer-center/)

---
JSON: https://onco.cc/api/v1/entities/paper-aldurdunji-saudi-clinicaltrials-gov-medicine-2026.json